Praeparatio cryodesiccata: interferonum beta-1b ADNr 0.3 mg corresp. 9.6 Mio U.I., albuminum humanum, mannitolum, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, pro vitro.
Solvens: natrii chloridum corresp. natrium 2.553 mg, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml.
Solutio reconstituta: interferonum beta-1b ADNr 0.25 mg corresp. 8 Mio U.I., albuminum humanum, mannitolum, natrii chloridum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium max. 2.955 mg.
Packungsbestandteile
Praeparatio cryodesiccata:
Lyophilisate and solvent
Active Agent
Dose
Interferonum Beta-1b Adnr
0.3 mg
BAG: Active Agent
Dose
Interferonum Beta-1b Adnr
0.3 mg
Inactive agents
Human Albumin
Mannitol
Sodium Hydroxide
Solvens
Lyophilisate and solvent
BAG: Active Agent
Dose
Interferonum Beta-1b Adnr
0.3 mg
Inactive agents
Sodium Chloride
Source
Data was imported : 03.02.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
